• 54,001+ CME Conference Registrations Sold
  • 162,002+ Medical Conferences
  • 285 Specialties
  • 11,618 Organizers
  • 158,729 Speakers
  • 159 Countries
  • 4,828 Cities
Home  >  Conferences  >  Radiopharmaceutical Therapy in Benign and Malignant Diseases: Radiotheragnostic Practicum
CME : 12.25

Radiopharmaceutical Therapy in Benign and Malignant Diseases: Radiotheragnostic Practicum

Sep 25 12:00 AM - Sep 26 12:00 AM, 2020   |   Las Vegas, Nevada  United States Of America
Organized by : Educational Symposia (ESI)
Specialties : Oncology   |   Radiology   |   Pharmacy and Medicine
Interested
Conference Brochure

Radiopharmaceutical Therapy in Benign and Malignant Diseases: Radiotheragnostic Practicum is organized by Educational Symposia (ESI) and will be held from Sep 25 - 26, 2020 at Wynn Las Vegas, Las Vegas, Nevada, United States of America.

Target Audience:
This meeting is designed for nuclear medicine physicians, nuclear radiologists, oncologists, nuclear medicine technologists, health physicists, and radiopharmacists.

Accreditation:
Educational Symposia designates this live activity for a maximum of 12.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Course Description:
The purpose of this CME course is to deliver to the audience the best practices in the growing field of radiotheragnostics (aka theranostics or theragnostics) for benign and malignant diseases, beginning with the fundamentals and extending to include their advanced clinical applications. The symposium has gathered an outstanding faculty with a vast practical and scientific experience in their designated topics. The overarching goal of each faculty is to arm the audience with the most comprehensive, relevant, and up-to-date knowledge, enabling them to optimally manage common as well as some unusual therapeutic challenges in their own practices. The symposium is intentionally structured to allocate each topic the attention and time that reflects the relative complexity and anticipated need in the nuclear medicine therapy practice. It includs some of the historically established therapies but optimally modernized as well as the recently introduced state-of-the-art modalities into the United States health care. The expert faculty will discuss the optimization of the radiotheragnostic practices for best utilization of various radiopharmaceuticals in contemporary health care delivery systems, both academic and private practice settings.

Educational Objectives
Attendees should, at the completion of this course, be able to:

• The difference between the radiotheragnostic approach and various other concepts guiding the therapeutic delivery of radiation to the target tissues with the objective of improving health outcomes.
• The best therapeutic practice approaches to hyperthyroidism and other benign thyroid diseases, based on evidence and/or sound medical judgment.
• The best therapeutic practice approaches to differentiated thyroid carcinoma, based on evidence and/or sound medical judgment.
• The optimal applications of Y-90 Ibritumomab Tiuxetan for therapy of lymphoma.
• The optimal applications of I-131 Iobenguane to diagnostic imaging and therapy of Pheochromocytoma and Paraganglioma.
• The optimal applications of Y-90 Resin and Glass Microspheres to radioembolization therapy of liver cancers.
• The optimal applications of Y-90 Resin and Glass Microspheres to radioembolization therapy of liver cancers.
• The optimal approach to diagnostic imaging of recurrent and metastatic prostate cancer.
• The best approach to therapy of skeletal metastatic disease using various Bone-Seeking radiopharmaceuticals.
• The practical examples for evaluation of not listed cancers for radiotheragnostics-based trials.
• Best approaches to building radiotheragnostic practice in academic institutions.
• Best approaches to building radiotheragnostic practice in private practice settings.

For the most updated conference information please visit the webpage: https://www.edusymp.com/product/details/1303

Note: This Course is also available as Webcast

Registration Desk

1(800) 828-2059

support@emedevents.com

Registration

Registration Type Last Date Price
Physicians, Scientists, Company Representatives Fee 24 Sep,2020 USD 1,195.00
P.A./R.A. Technologists, Retired Physicians, Sonographers, Active Military, VA Physicians Fee 24 Sep,2020 USD 875.00
Residents, Fellows Fee 24 Sep,2020 USD 597.00
Interested
  • Drive Walk Transit Bicycle

Venue Address

Wynn Las Vegas
3131 S Las Vegas Blvd
Las Vegas, Nevada, United States Of America

Official Hotel

Wynn Las Vegas,

3131 S Las Vegas Blvd,

Las Vegas, Nevada, United States of America 89109,

+1 702-770-7000

Plan Your Travel

Hotel Dealing
Hotel
Flights
flights
Cars
Rides
Traveller insurance
Traveller insurance

Please Rate this Conference

 0.0
 0.0
 0.0
 0.0
 0.0

Reviews Given by People

No Reviews available. Be the first to write a review.

Hotels Near Venue

Golden Nugget Hotel & Casino Las Vegas
3.9 miles from venue
, Free Wifi Free Wifi
Price : USD 49.00 Per Night
Mandalay Bay Resort And Casino
1.87 miles from venue
Price : USD 89.00 Per Night
Delano Las Vegas At Mandalay Bay
1.87 miles from venue
Price : USD 99.00 Per Night
SAHARA Las Vegas
1.83 miles from venue
Price : USD 49.00 Per Night
Close

Session Details

Session Topic Start Time End Time Location Speakers
Close

Workshop Details

Title Start Time End Time Workshop Fee

Subscribe to our Newsletter

x

Subscribe to our newsletter and receive updates on medical conferences, board review courses and news